Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

View:
Post by digitalstone on May 02, 2024 7:24am

News Out

Man oh Man !  Good news, but pushing the Break Through Designation back again ... really ?
Frustrating!

"Supporting Break Through Designation approval from the FDA in 3Q2024."
Comment by Lesalpes29 on May 02, 2024 7:26am
Pre-BTD Q2 and full BTD in Q3? And AA before year end. GL
Comment by Oilminerdeluxe on May 02, 2024 7:42am
I suspect those two cost a bit of money. Sooo, one might suspect good news to be locked in for the next Q or so. One can hope at least..
Comment by enriquesuave on May 02, 2024 9:17am
It was expected end of Q2 beginning of Q3.  I hope it's still first half of Q3 for BTD.
Comment by stocksnbonds458 on May 02, 2024 9:58pm
I think the best case scenario is to have the FDA's pre-btd questions answered and submitted by sometime in Q3. The actual BTD submission would then likely be sometime Q4, with an answer from the FDA early 2025.  The process is agonizingly long when you don't have deep pockets.
Comment by Infinity on May 03, 2024 12:02pm
One would think that the TLT Management would have known about this agonizingly slow processing time for BTD Applications when they made the forecast that BTD a possibility in 1st quarter 2024.  As far as I know, TLT has not even completed the Pre- BTD and obtained guidance to go ahaed with the formal  BTD application.  We all know TLT obtained Fast Track status before COVID hit us. ...more  
Comment by managementfirst on May 03, 2024 12:22pm
Very fair words---I think frequent changes in Management is the main reason for the lack of continuity.  Dr. Shirazi was doing fine for a few years, folliwed by Dr. Vera Madzarvic, few more on the Device side of the business as well.  Leads me to believe RDW either has a real problem in holding on to skilled and talented people that he hired in the first place or he tends to hire the ...more  
Comment by StevenBirch on May 03, 2024 12:22pm
When you're ready to sell let me know and I'll hop on the bid.
Comment by Infinity on May 03, 2024 3:40pm
Sure thing.  But why wait for me to sell?.  What is stopping you from jumping in now and buy at $0.16.  I don't think it is going to get much lower!!.  If I were in the market to buy TLT I would do it now!!.  Hoping you would take advantage of the low price and build up your stockpile!
Comment by Legit62 on May 02, 2024 12:55pm
Probably 2nd quarter 2025 from the looks of it, dissapointed another timeline missed but holding shares, too much of a loss to dump now unfortunately
Comment by Infinity on May 03, 2024 2:56pm
Agree with you.  Not much is likely to happen before 2nd quarter 2025.  RDW has Dr. Jewett, as a consultant.  Hopefully he is able to speed up enrollment in the clinical trials and increase more study sites..  We have been bogged down at 63 patients for way too long..
Comment by Infinity on May 02, 2024 12:57pm
I think they are refering to BTD final Approval from FDA in 3rd Quarter.  I believe, they will apply for PRE BTD this quarter and Formal BTD soon after and get an answer back within 60 Days.  BTD  approval cannot be earlier than 3rd quarter at best.
Comment by Galaxym31 on May 02, 2024 1:04pm
Day after warrants expire .
Comment by riverrrow on May 02, 2024 3:52pm
Management should just come clean and admit they have no idea when they will submit their BTD application.
Comment by Dumbeldorfwhite on May 02, 2024 4:19pm
You know it's bad when Mr. Try to spin it river boi is upset.
Comment by TimboBaggins on May 02, 2024 5:42pm
and why it's taking so long. Just be honest. If it was a screw up, how big of a screw up? 
Comment by toade1313 on May 02, 2024 9:07pm
They should hire someone that can wrote press releases on issues shareholders want to hear about - positive or negative. Avoiding the subject leads to shareholder discontent and following SP declines. 
Comment by Dumbeldorfwhite on May 02, 2024 11:03pm
Why when you can sue people to keep their mouths shut
Comment by Kayz88 on May 02, 2024 10:27pm
They pushed it back in Q1 didn't they? They started inching away from the Q2 deadline and now committed to Q3? I don't know anymore...
Comment by Dumbeldorfwhite on May 02, 2024 11:09pm
Because like I said years ago, the clinical team doesn't appear to be adequate to handle a trial of this magnitude, which is evident by the sloppiness of the trial (not treating the first 12 correctly, not planning enough money, not having the enrollment expected, not expecting 450 day data) Dont even get me started on the "GLP" studies, if I had to guess they won't get done ...more  
Comment by Galaxym31 on May 03, 2024 11:04am
Hire some high school science geeks .
Comment by reconsider on May 03, 2024 10:18am
Do you remember when we were told that BTD submission could be "a question of days"? That didn't aged well... If this 2024 I don't see BTD or licensing/partnering agreement I'll be out.  GLTA
Comment by riverrrow on May 03, 2024 10:57am
I had a firm deadline to get out of TLT based on performance or lack thereof a couple of years ago and yet here I am.  GLTA.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250